Mabqi is proud to co-author the scientific article « Discovery and preclinical characterization of potent anti-RGMb antibodies blocking multiple ligand bindings» published in mAbs, November 2024.
The research project led by IOME Bio focused on developing antibodies targeting Repulsive Guidance Molecule b (RGMb), a novel...